showed a trendp=0.08
Patients developing ABMR during follow-up showed a trend towards higher amino acid MM (88±5 vs. 63±22, p=0.08); global PIRCHE-II (117±48 vs. 80±38, p=0.06) and higher eplet MM load (41.5±7 vs. 32±11, p=0.07).
Patients developing ABMR during follow-up showed a trend towards higher amino acid MM (88±5 vs. 63±22, p=0.08); global PIRCHE-II (117±48 vs. 80±38, p=0.06) and higher eplet MM load (41.5±7 vs. 32±11, p=0.07).